Experiment 1182149

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationFALKSON,G: VOROBIOF,DA: SIMSON,IW: BORDEN,EC:. (1987). PHASE II TRIAL OF ACIVICIN IN MALIGNANT MESOTHELIOMA.. 71(5)
Amount utilized
Compound isolated
DiseaseIN THIS PHASE II CLINICAL TRIAL,23 PATIENTS WITH MALIGNANT MESOTHIOLOMA WERE TREATED. THERAPY CONSISTED OF ACIVICIN BY 72 HOUR IV INFUSION REPEATED EVERY 21 DAYS. TOXICITY INCLUDED LEUKOPENIA, ANEMIA,NEUROLOGIC TOXICITY,KIDNEY EFFECTS,STOMATITIS,DIARRHEA,NAUSEA AND VOMITING.
Dose amount20.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE